Sfoglia per Autore
Bleeding risk in very old patients on vitamin K antagonist treatment: results of a prospective collaborative study on elderly patients followed by Italian Centres for Anticoagulation
2011-01-01 Poli, D; Antonucci, E; Testa, S; Tosetto, A; Ageno, W; Palareti, G; Barcellona, Doris; Marongiu, Francesco
A routine silica-based activated partial thromboplastin time (Hemosil aPTT-SP (TM)) mostly excludes the presence of lupus anticoagulant
2011-01-01 Mameli, A; Barcellona, Doris; Vannini, Ml; Marongiu, Francesco
Thyroid disorders and hypocoagulability
2011-01-01 Marongiu, Francesco; Barcellona, Doris; Mameli, A; Mariotti, Stefano
High frequency of inadequate test requests for antiphospholipid antibodies in daily clinical practice
2011-01-01 Mameli, A; Barcellona, Doris; Vannini, Ml; Marongiu, Francesco
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA)
2010-01-01 Pengo, V; Denas, G; Bison, E; Banzato, A; Jose, Sp; Gresele, P; Marongiu, Francesco; Erba, N; Veschi, F; Ghirarduzzi, A; De Candia, E; Montaruli, B; Marietta, M; Testa, S; Barcellona, Doris; Tripodi, A.
Clinical course of high-risk patients diagnosed with antiphospholipid syndrome
2010-01-01 Pengo, V; Ruffatti, A; Legnani, C; Gresele, P; Barcellona, Doris; Erba, N; Testa, S; Marongiu, Francesco; Bison, E; Denas, G; Banzato, A; Jose, Sp; Iliceto, S.
Point-of-care (POCT) prothrombin time monitors: is a periodical control of their performance useful?
2009-01-01 Barcellona, Doris; Fenu, L; Cornacchini, S; Marongiu, Francesco
Rheumatoid arthritis and thrombosis
2009-01-01 Mameli, A; Barcellona, Doris; Marongiu, Francesco
A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without
2007-01-01 Pengo, V; Biasiolo, A; Gresele, P; Marongiu, Francesco; Erba, N; Veschi, F; Ghirarduzzi, A; Barcellona, Doris; Tripodi, A.
Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples
2007-01-01 Pengo, V; Biasiolo, A; Gresele, P; Marongiu, Francesco; Erba, N; Veschi, F; Ghirarduzzi, A; De Candia, E; Montaruli, B; Testa, S; Barcellona, Doris; Tripodi, A.
Oral anticoagulant therapy and telemedicine
2006-01-01 Barcellona, Doris; Fenu, Lara; Minozzi, M.
A ‘‘two-step’’ educational approach for patients taking oral anticoagulants does not improve therapy control
2006-01-01 Barcellona, Doris; Contu, Paolo; Marongiu, Francesco
The future of anticoagulation clinics: a journey to thrombosis centers?
2005-01-01 Marongiu, Francesco; Barcellona, Doris
Oral anticoagulant therapy in the primary and secondary prophylaxis of stroke
2003-01-01 Cauli, C; Barcellona, Doris; Marongiu, Francesco
Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided?
2003-01-01 Marongiu, Francesco; Fenu, Lara; G., Pisu; Contu, Paolo; Barcellona, Doris
Allele 4G of gene PAI-I associated with prothrombin mutation G20210A increases the risk for venous thrombosis
2003-01-01 Barcellona, Doris; Fenu, Lara; Cauli, C; Pisu, G; Marongiu, Francesco
A guide to oral anticoagulation
2003-01-01 Prisco, D; Barcellona, Doris; Baudo, F; Berretini, M; Ciavarella, N; Cosmi, B; Dettori, Ag; Finazzi, G; Manotti, C; Marongiu, Francesco; Moia, M; Palareti, G; Pengo, V; Poli, D; Testa, S; Tripodi, A.
Patient education and oral anticoagulant therapy
2002-01-01 Barcellona, Doris; Contu, Paolo; Marongiu, Francesco
The management of oral anticoagulant therapy: the patient's point of view
2000-01-01 Barcellona, Doris; Contu, Paolo; Sorano, Gg; Pengo, V; Marongiu, Francesco
Warfarin or acenocoumarol: which is better in the management of oral anticoagulants?
1998-01-01 Barcellona, Doris; Vannini, Ml; Fenu, L; Balestrieri, C; Marongiu, Francesco
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile